simendan has been researched along with Hyperglycemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelrahman, AM; Al Salam, S; Al Suleimani, Y; Ali, BH; Ashique, M; Manoj, P | 1 |
| Feige, K; Heinen, A; Hollmann, MW; Huhn, R; Raupach, A; Ruske, R; Stroethoff, M; Torregroza, C; Yueksel, B | 1 |
| Cho, S; Hara, T; Higashijima, U; Maekawa, T; Matsumoto, S; Sumikawa, K; Tosaka, S | 1 |
3 other study(ies) available for simendan and Hyperglycemia
| Article | Year |
|---|---|
Effect of levosimendan, an inodilator, on streptozotocin-induced diabetic nephropathy in rats.
Topics: Animals; Antioxidants; Blood Glucose; Body Weight; Cardiotonic Agents; Cytokines; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibrosis; Hyperglycemia; Kidney; Male; Oxidative Stress; Polyuria; Rats; Rats, Sprague-Dawley; Simendan | 2020 |
Combination of Cyclosporine A and Levosimendan Induces Cardioprotection under Acute Hyperglycemia.
Topics: Animals; Cardiotonic Agents; Cyclosporine; Disease Models, Animal; Heart; Hyperglycemia; Male; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Membranes; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Wistar; Simendan | 2021 |
Hyperglycemia raises the threshold of levosimendan- but not milrinone-induced postconditioning in rat hearts.
Topics: Animals; Blood Glucose; Disease Models, Animal; Hemodynamics; Hydrazones; Hyperglycemia; Male; Milrinone; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Pyridazines; Rats; Rats, Wistar; Simendan; Time Factors | 2012 |